SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b):
SEC Accession No. 0001193125-14-235209
Filing Date
2014-06-13
Accepted
2014-06-12 21:27:07
Documents
9
Period of Report
2014-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K12B d743580d8k12b.htm 8-K12B 37291
2 EX-2.1 d743580dex21.htm EX-2.1 24869
3 EX-3.1 d743580dex31.htm EX-3.1 24319
4 EX-3.2 d743580dex32.htm EX-3.2 111195
5 EX-4.1 d743580dex41.htm EX-4.1 14696
6 EX-10.1 d743580dex101.htm EX-10.1 64246
7 EX-10.2 d743580dex102.htm EX-10.2 147775
8 EX-10.3 d743580dex103.htm EX-10.3 54519
9 GRAPHIC g743580im1.jpg GRAPHIC 213041
  Complete submission text file 0001193125-14-235209.txt   774302
Mailing Address 11095 FLINTKOTE AVE. SUITE D SAN DIEGO CA 92121
Business Address 11095 FLINTKOTE AVE. SUITE D SAN DIEGO CA 92121 (858) 255-5959
Ignyta, Inc. (Filer) CIK: 0001557421 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K12B | Act: 34 | File No.: 001-36344 | Film No.: 14908510
SIC: 2834 Pharmaceutical Preparations